세계의 사전지시서 시장 - 시장 규모, 점유율, 동향 분석 보고서 :컴포넌트별, 최종 사용자별, 데모 그래픽별, 지역별 전망 및 예측(2023-2030년)

The Global Advance Directives Market size is expected to reach $358.7 billion by 2030, rising at a market growth of 16.5% CAGR during the forecast period.

Payers are responsible for developing policies that guide their interactions with healthcare providers and policyholders. Incorporating advance directives into these policies ensures the payer organization is aligned with legal and ethical standards for honoring patient preferences. Consequently, the Payers segment would generate approximately 29.44% share of the market by 2030. Payers engage in population health management to optimize the health outcomes of their covered populations. Understanding their members' advance care planning status enables payers to tailor outreach programs, educational initiatives, and support services. Some of the factors affecting the market are technological advancements and digital solutions, growing proportion of the aging population, and complexity of legal and medical language.

Technological progress has significantly changed advance directives, rendering them more readily available and effective. Securing electronic repositories that can store, retrieve, and transmit advance directives at any time and from any location is a noteworthy development. These repositories enable users to designate a spokesperson, electronically complete and save advance directives, and provide fundamental data warehousing capabilities. Moreover, Due to the abovementioned aspects, the market growth is expected to expand significantly. An increased prevalence of chronic and life-limiting illnesses often accompanies aging. As individuals age, they may face complex healthcare decisions. The desire to have a say in their medical care, especially during critical moments, prompts many seniors to engage in advance care planning and create advance directives. Thus, the growing proportion of the aging population is a key driver that positively expands the market.

However, Legal and medical terminology can be highly technical and challenging for the general public. Individuals may feel overwhelmed or intimidated by the language used in advance directives, leading to a reluctance to engage in advance care planning. The presence of complex language may discourage individuals from initiating conversations about advance care planning with healthcare providers or family members. Due to the above factors, market growth will be hampered in the coming years.

Component Outlook

On the basis of components, the market is segmented into software and services. In 2022, the services segment dominated the market with the maximum revenue share. This is because these services provide individuals with guidance through the intricacies of end-of-life planning, which is an intrinsic value. The anticipated rise in demand for expert guidance and comprehensive support can be attributed to the growing recognition of the significance of advance directives. The significance of advance directive services in influencing the field of advance directive solutions is highlighted by this expected expansion.

End User Outlook

By end user, the market is classified into B2B and B2C. The B2C segment acquired a substantial revenue share in the market in 2022. B2C consumers can explore mobile apps and digital platforms for advanced care planning. These tools may provide interactive features, reminders for updating directives, and secure storage options for digital copies of advance directives. B2C users can seek information from patient advocacy organizations focusing on end-of-life care and advance care planning. These organizations often provide resources, support, and advocacy for individuals navigating the complexities of healthcare decision-making. These events may focus on advance care planning, allowing individuals to learn more and initiate the process of creating advance directives.

B2B Outlook

Under B2B type, the market is further divided into healthcare providers and payers. In 2022, the healthcare providers segment registered the highest revenue share in the market. Hospice organizations, hospitals, and clinics are among the healthcare providers with the ability and knowledge to initiate discussions regarding advance directives (AD), inform patients of their available choices, and assist them in developing legally binding documents, including AD. Healthcare professionals increasingly acknowledge the importance of observing patients' end-of-life treatment preferences in light of the expanding focus on patient-centered care. Additionally, their participation aids in balancing medical treatment with patients' values while ensuring patients' preferences are fulfilled.

Demographics Outlook

Based on demographics, the market is fragmented into elderly population (65 yrs & above), middle aged (40-64 yrs), and young adults (18-39 yrs). In 2022, the elderly population (65 yrs & above) segment held the highest revenue share in the market. The significance of advance directives is becoming increasingly acknowledged among the geriatric population, as illustrated by this projection. There is a growing concern regarding end-of-life preparations as the elderly demographic expands. A significant increase in demand is expected for advance directive services, discussions, and documentation in this sector, which reflects the societal trend toward proactive healthcare planning.

Regional Outlook

Region-wise, the market is analysed across North America, Europe, Asia Pacific, and LAMEA. The Asia Pacific region covered a considerable revenue share in the market in 2022. A convergence of factors propels the Asian market to develop rapidly. There is a growing emphasis on patient-centered and individualized healthcare as societies progress in age and cultural perspectives evolve. Healthcare systems strive to optimize resource allocation, while technology integration has increased the accessibility of Advance Directives. Patient autonomy and shared decision-making are also reinforced through policy initiatives and regulatory support.

The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include ADVault, Inc., VynaCare, WiserCare Inc., Sharp Healthcare, Affirm Health Inc., Thanacare, Honor My Decision LLC, Koda Health, ThoroughCare, Inc., Vital Decisions LLC (Evolent Health LLC).

Scope of the Study

Market Segments covered in the Report:

By Component

• Services
• Software

By End User

• B2B
  • Healthcare Providers
  • Payers
• B2C

By Demographics

• Elderly Population (65 yrs & above)
• Middle Aged (40-64 yrs)
• Young Adults (18-39 yrs)

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled

• ADVault, Inc.
• VynaCare
• WiserCare Inc.
• Sharp Healthcare
• Affirm Health Inc.
• Thanacare
• Honor My Decision LLC
• Koda Health
• ThoroughCare, Inc.
• Vital Decisions LLC (Evolent Health LLC)

Unique Offerings from KBV Research

• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

• 1.1 Market Definition
• 1.2 Objectives
• 1.3 Market Scope
• 1.4 Segmentation
  • 1.4.1 Global Advance Directives Market, by Component
  • 1.4.2 Global Advance Directives Market, by End User
  • 1.4.3 Global Advance Directives Market, by Demographics
  • 1.4.4 Global Advance Directives Market, by Geography
• 1.5 Methodology for the research

Chapter 2. Market at a Glance

• 2.1 Key Highlights

Chapter 3. Market Overview

• 3.1 Introduction
  • 3.1.1 Overview
    • 3.1.1.1 Market Composition and Scenario
• 3.2 Key Factors Impacting the Market
  • 3.2.1 Market Drivers
  • 3.2.2 Market Restraints
• 3.3 Porter's Five Forces Analysis

Chapter 4. Global Advance Directives Market, By Component

• 4.1 Global Services Market, By Region
• 4.2 Global Software Market, By Region

Chapter 5. Global Advance Directives Market, By End User

• 5.1 Global B2B Market, By Region
• 5.2 Global Advance Directives Market, By B2B Type
  • 5.2.1 Global Healthcare Providers Market, By Region
  • 5.2.2 Global Payers Market, By Region
• 5.3 Global B2C Market, By Region

Chapter 6. Global Advance Directives Market, By Demographics

• 6.1 Global Elderly Population (65 yrs & above) Market, By Region
• 6.2 Global Middle Aged (40-64 yrs) Market, By Region
• 6.3 Global Young Adults (18-39 yrs) Market, By Region

Chapter 7. Global Advance Directives Market, By Region

• 7.1 North America Advance Directives Market
  • 7.1.1 North America Advance Directives Market, By Component
    • 7.1.1.1 North America Services Market, By Country
    • 7.1.1.2 North America Software Market, By Country
  • 7.1.2 North America Advance Directives Market, By End User
    • 7.1.2.1 North America B2B Market, By Country
    • 7.1.2.2 North America Advance Directives Market, By B2B Type
      • 7.1.2.2.1 North America Healthcare Providers Market, By Country
      • 7.1.2.2.2 North America Payers Market, By Country
    • 7.1.2.3 North America B2C Market, By Country
  • 7.1.3 North America Advance Directives Market, By Demographics
    • 7.1.3.1 North America Elderly Population (65 yrs & above) Market, By Country
    • 7.1.3.2 North America Middle Aged (40-64 yrs) Market, By Country
    • 7.1.3.3 North America Young Adults (18-39 yrs) Market, By Country
  • 7.1.4 North America Advance Directives Market, By Country
    • 7.1.4.1 US Advance Directives Market
      • 7.1.4.1.1 US Advance Directives Market, By Component
      • 7.1.4.1.2 US Advance Directives Market, By End User
      • 7.1.4.1.3 US Advance Directives Market, By Demographics
    • 7.1.4.2 Canada Advance Directives Market
      • 7.1.4.2.1 Canada Advance Directives Market, By Component
      • 7.1.4.2.2 Canada Advance Directives Market, By End User
      • 7.1.4.2.3 Canada Advance Directives Market, By Demographics
    • 7.1.4.3 Mexico Advance Directives Market
      • 7.1.4.3.1 Mexico Advance Directives Market, By Component
      • 7.1.4.3.2 Mexico Advance Directives Market, By End User
      • 7.1.4.3.3 Mexico Advance Directives Market, By Demographics
    • 7.1.4.4 Rest of North America Advance Directives Market
      • 7.1.4.4.1 Rest of North America Advance Directives Market, By Component
      • 7.1.4.4.2 Rest of North America Advance Directives Market, By End User
      • 7.1.4.4.3 Rest of North America Advance Directives Market, By Demographics
• 7.2 Europe Advance Directives Market
  • 7.2.1 Europe Advance Directives Market, By Component
    • 7.2.1.1 Europe Services Market, By Country
    • 7.2.1.2 Europe Software Market, By Country
  • 7.2.2 Europe Advance Directives Market, By End User
    • 7.2.2.1 Europe B2B Market, By Country
    • 7.2.2.2 Europe Advance Directives Market, By B2B Type
      • 7.2.2.2.1 Europe Healthcare Providers Market, By Country
      • 7.2.2.2.2 Europe Payers Market, By Country
    • 7.2.2.3 Europe B2C Market, By Country
  • 7.2.3 Europe Advance Directives Market, By Demographics
    • 7.2.3.1 Europe Elderly Population (65 yrs & above) Market, By Country
    • 7.2.3.2 Europe Middle Aged (40-64 yrs) Market, By Country
    • 7.2.3.3 Europe Young Adults (18-39 yrs) Market, By Country
  • 7.2.4 Europe Advance Directives Market, By Country
    • 7.2.4.1 Germany Advance Directives Market
      • 7.2.4.1.1 Germany Advance Directives Market, By Component
      • 7.2.4.1.2 Germany Advance Directives Market, By End User
      • 7.2.4.1.3 Germany Advance Directives Market, By Demographics
    • 7.2.4.2 UK Advance Directives Market
      • 7.2.4.2.1 UK Advance Directives Market, By Component
      • 7.2.4.2.2 UK Advance Directives Market, By End User
      • 7.2.4.2.3 UK Advance Directives Market, By Demographics
    • 7.2.4.3 France Advance Directives Market
      • 7.2.4.3.1 France Advance Directives Market, By Component
      • 7.2.4.3.2 France Advance Directives Market, By End User
      • 7.2.4.3.3 France Advance Directives Market, By Demographics
    • 7.2.4.4 Russia Advance Directives Market
      • 7.2.4.4.1 Russia Advance Directives Market, By Component
      • 7.2.4.4.2 Russia Advance Directives Market, By End User
      • 7.2.4.4.3 Russia Advance Directives Market, By Demographics
    • 7.2.4.5 Spain Advance Directives Market
      • 7.2.4.5.1 Spain Advance Directives Market, By Component
      • 7.2.4.5.2 Spain Advance Directives Market, By End User
      • 7.2.4.5.3 Spain Advance Directives Market, By Demographics
    • 7.2.4.6 Italy Advance Directives Market
      • 7.2.4.6.1 Italy Advance Directives Market, By Component
      • 7.2.4.6.2 Italy Advance Directives Market, By End User
      • 7.2.4.6.3 Italy Advance Directives Market, By Demographics
    • 7.2.4.7 Rest of Europe Advance Directives Market
      • 7.2.4.7.1 Rest of Europe Advance Directives Market, By Component
      • 7.2.4.7.2 Rest of Europe Advance Directives Market, By End User
      • 7.2.4.7.3 Rest of Europe Advance Directives Market, By Demographics
• 7.3 Asia Pacific Advance Directives Market
  • 7.3.1 Asia Pacific Advance Directives Market, By Component
    • 7.3.1.1 Asia Pacific Services Market, By Country
    • 7.3.1.2 Asia Pacific Software Market, By Country
  • 7.3.2 Asia Pacific Advance Directives Market, By End User
    • 7.3.2.1 Asia Pacific B2B Market, By Country
    • 7.3.2.2 Asia Pacific Advance Directives Market, By B2B Type
      • 7.3.2.2.1 Asia Pacific Healthcare Providers Market, By Country
      • 7.3.2.2.2 Asia Pacific Payers Market, By Country
    • 7.3.2.3 Asia Pacific B2C Market, By Country
  • 7.3.3 Asia Pacific Advance Directives Market, By Demographics
    • 7.3.3.1 Asia Pacific Elderly Population (65 yrs & above) Market, By Country
    • 7.3.3.2 Asia Pacific Middle Aged (40-64 yrs) Market, By Country
    • 7.3.3.3 Asia Pacific Young Adults (18-39 yrs) Market, By Country
  • 7.3.4 Asia Pacific Advance Directives Market, By Country
    • 7.3.4.1 China Advance Directives Market
      • 7.3.4.1.1 China Advance Directives Market, By Component
      • 7.3.4.1.2 China Advance Directives Market, By End User
      • 7.3.4.1.3 China Advance Directives Market, By Demographics
    • 7.3.4.2 Japan Advance Directives Market
      • 7.3.4.2.1 Japan Advance Directives Market, By Component
      • 7.3.4.2.2 Japan Advance Directives Market, By End User
      • 7.3.4.2.3 Japan Advance Directives Market, By Demographics
    • 7.3.4.3 India Advance Directives Market
      • 7.3.4.3.1 India Advance Directives Market, By Component
      • 7.3.4.3.2 India Advance Directives Market, By End User
      • 7.3.4.3.3 India Advance Directives Market, By Demographics
    • 7.3.4.4 South Korea Advance Directives Market
      • 7.3.4.4.1 South Korea Advance Directives Market, By Component
      • 7.3.4.4.2 South Korea Advance Directives Market, By End User
      • 7.3.4.4.3 South Korea Advance Directives Market, By Demographics
    • 7.3.4.5 Singapore Advance Directives Market
      • 7.3.4.5.1 Singapore Advance Directives Market, By Component
      • 7.3.4.5.2 Singapore Advance Directives Market, By End User
      • 7.3.4.5.3 Singapore Advance Directives Market, By Demographics
    • 7.3.4.6 Malaysia Advance Directives Market
      • 7.3.4.6.1 Malaysia Advance Directives Market, By Component
      • 7.3.4.6.2 Malaysia Advance Directives Market, By End User
      • 7.3.4.6.3 Malaysia Advance Directives Market, By Demographics
    • 7.3.4.7 Rest of Asia Pacific Advance Directives Market
      • 7.3.4.7.1 Rest of Asia Pacific Advance Directives Market, By Component
      • 7.3.4.7.2 Rest of Asia Pacific Advance Directives Market, By End User
      • 7.3.4.7.3 Rest of Asia Pacific Advance Directives Market, By Demographics
• 7.4 LAMEA Advance Directives Market
  • 7.4.1 LAMEA Advance Directives Market, By Component
    • 7.4.1.1 LAMEA Services Market, By Country
    • 7.4.1.2 LAMEA Software Market, By Country
  • 7.4.2 LAMEA Advance Directives Market, By End User
    • 7.4.2.1 LAMEA B2B Market, By Country
    • 7.4.2.2 LAMEA Advance Directives Market, By B2B Type
      • 7.4.2.2.1 LAMEA Healthcare Providers Market, By Country
      • 7.4.2.2.2 LAMEA Payers Market, By Country
    • 7.4.2.3 LAMEA B2C Market, By Country
  • 7.4.3 LAMEA Advance Directives Market, By Demographics
    • 7.4.3.1 LAMEA Elderly Population (65 yrs & above) Market, By Country
    • 7.4.3.2 LAMEA Middle Aged (40-64 yrs) Market, By Country
    • 7.4.3.3 LAMEA Young Adults (18-39 yrs) Market, By Country
  • 7.4.4 LAMEA Advance Directives Market, By Country
    • 7.4.4.1 Brazil Advance Directives Market
      • 7.4.4.1.1 Brazil Advance Directives Market, By Component
      • 7.4.4.1.2 Brazil Advance Directives Market, By End User
      • 7.4.4.1.3 Brazil Advance Directives Market, By Demographics
    • 7.4.4.2 Argentina Advance Directives Market
      • 7.4.4.2.1 Argentina Advance Directives Market, By Component
      • 7.4.4.2.2 Argentina Advance Directives Market, By End User
      • 7.4.4.2.3 Argentina Advance Directives Market, By Demographics
    • 7.4.4.3 UAE Advance Directives Market
      • 7.4.4.3.1 UAE Advance Directives Market, By Component
      • 7.4.4.3.2 UAE Advance Directives Market, By End User
      • 7.4.4.3.3 UAE Advance Directives Market, By Demographics
    • 7.4.4.4 Saudi Arabia Advance Directives Market
      • 7.4.4.4.1 Saudi Arabia Advance Directives Market, By Component
      • 7.4.4.4.2 Saudi Arabia Advance Directives Market, By End User
      • 7.4.4.4.3 Saudi Arabia Advance Directives Market, By Demographics
    • 7.4.4.5 South Africa Advance Directives Market
      • 7.4.4.5.1 South Africa Advance Directives Market, By Component
      • 7.4.4.5.2 South Africa Advance Directives Market, By End User
      • 7.4.4.5.3 South Africa Advance Directives Market, By Demographics
    • 7.4.4.6 Nigeria Advance Directives Market
      • 7.4.4.6.1 Nigeria Advance Directives Market, By Component
      • 7.4.4.6.2 Nigeria Advance Directives Market, By End User
      • 7.4.4.6.3 Nigeria Advance Directives Market, By Demographics
    • 7.4.4.7 Rest of LAMEA Advance Directives Market
      • 7.4.4.7.1 Rest of LAMEA Advance Directives Market, By Component
      • 7.4.4.7.2 Rest of LAMEA Advance Directives Market, By End User
      • 7.4.4.7.3 Rest of LAMEA Advance Directives Market, By Demographics

Chapter 8. Company Profiles

• 8.1 ADVault, Inc.
  • 8.1.1 Company Overview
  • 8.1.2 Recent strategies and developments:
    • 8.1.2.1 Partnerships, Collaborations, and Agreements:
  • 8.1.3 SWOT Analysis
• 8.2 VynaCare
  • 8.2.1 Company Overview
  • 8.2.2 SWOT Analysis
• 8.3 WiserCare Inc.
  • 8.3.1 Company Overview
  • 8.3.2 SWOT Analysis
• 8.4 Sharp HealthCare
  • 8.4.1 Company Overview
  • 8.4.2 SWOT Analysis
• 8.5 AffirmHealth Inc.
  • 8.5.1 Company Overview
  • 8.5.2 SWOT Analysis
• 8.6 Thanacare
  • 8.6.1 Company Overview
  • 8.6.2 SWOT Analysis
• 8.7 Koda Health, Inc.
  • 8.7.1 Company Overview
  • 8.7.2 SWOT Analysis
• 8.8 ThoroughCare, Inc.
  • 8.8.1 Company Overview
  • 8.8.2 SWOT Analysis
• 8.9 Vital Decision, LLC (Evolent Health LLC)
  • 8.9.1 Company Overview
  • 8.9.2 SWOT Analysis
• 8.10. Honor My Decisions LLC
  • 8.10.1 Company Overview

Chapter 9. Winning Imperatives of Advance Directives Market